Skip to content

Understanding Disparities in Quitting in African American and White Smokers

Understanding Disparities in Quitting in African American and White Smokers

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01836276
Enrollment
449
Registered
2013-04-19
Start date
2013-02-28
Completion date
2017-04-30
Last updated
2018-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation

Brief summary

The purpose of this study is to describe the differences in quitting smoking between African Americans (AA) and White smokers treated with varenicline.

Detailed description

While many studies have evaluated the use of drugs for quitting smoking among Whites, few have assessed efficacy with AAs. Racial/ethical differences in smoking are well documented. AAs smoke less than White smokers but experience disproportionately greater smoking disease and death. Past studies by the researchers in this study looked at how effective other smoking cessation methods are in AAs. These methods included nicotine gum, nicotine patch and buproprion sustained release. This study will be evaluating varenicline in both AA and White smokers. There has not been a study conducted yet to prospectively research AA-White differences in smoking cessation and also to examine potential causal pathways explaining AA-White differences in quitting.

Interventions

DRUGVarenicline

1 mg of varenicline twice daily after titration to full strength in the first week following standard dosing guidelines

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Pfizer
CollaboratorINDUSTRY
Nikki Nollen, PhD, MA
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Non-Hispanic African American or non-Hispanic White * ≥ 18 years of age * Smoked 3-20 cigarettes per day * Smoked on \>25 days of the past 30 days * Functioning telephone * Interested in quitting smoking * Interested in taking 3 months of varenicline * Willing to complete all study visits

Exclusion criteria

* Renal impairment * Evidence or history of clinically significant allergic reactions to varenicline * A cardiovascular event in the past month Hospitalization in the past 2 months for any cardiovascular disease, including but not limited to: * Angina * Myocardial infarction * Peripheral vascular disease * Stroke * New onset of chest pain or arrhythmia in the past 2 months * History of alcohol or drug dependency in the past year * Major depressive disorder in the last year requiring treatment * History of panic disorder, psychosis, bipolar disorder, or eating disorders * Use of tobacco products other than cigarettes in past 30 days * Use of pharmacotherapy in the month prior to enrollment, including prior use of varenicline * Pregnant, contemplating getting pregnant, or breastfeeding * Plans to move from Kansas City during the treatment and follow-up phase * Another household member enrolled in the study

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Cotinine-verified 7-day Point Prevalence Smoking Abstinence at Week 26Change from Baseline to Week 26Defined as having no cigarettes for the previous 7 days at the Week 26 visit. The recommended cut-off of 15ng/ml for salivary cotinine will be used to differentiate smokers from non-smokers.

Countries

United States

Participant flow

Participants by arm

ArmCount
African American
12 weeks of varenicline and 6 counseling sessions.
224
White
12 weeks of varenicline and 6 counseling sessions.
225
Total449

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up2851

Baseline characteristics

CharacteristicTotalAfrican AmericanWhite
Age, Continuous41.4 years
STANDARD_DEVIATION 11.6
42.4 years
STANDARD_DEVIATION 12
40.5 years
STANDARD_DEVIATION 11.2
Age when you started smoking regularly17.5 years
STANDARD_DEVIATION 5.8
18.5 years
STANDARD_DEVIATION 6.5
16.5 years
STANDARD_DEVIATION 4.8
Anxiety2.5 units on a scale
STANDARD_DEVIATION 3.2
3.0 units on a scale
STANDARD_DEVIATION 3.6
2.1 units on a scale
STANDARD_DEVIATION 2.7
BMI29.8 kg/m^2
STANDARD_DEVIATION 7.7
30.8 kg/m^2
STANDARD_DEVIATION 8.1
28.9 kg/m^2
STANDARD_DEVIATION 7.1
Cigarettes per day14.7 Cigarettes
STANDARD_DEVIATION 5.7
12.5 Cigarettes
STANDARD_DEVIATION 5.7
16.9 Cigarettes
STANDARD_DEVIATION 4.6
Cohabitation Status
Living alone
257 Participants142 Participants115 Participants
Cohabitation Status
Living with a partner
192 Participants82 Participants110 Participants
Craving14.7 units on a scale
STANDARD_DEVIATION 7.3
14.1 units on a scale
STANDARD_DEVIATION 7.9
15.3 units on a scale
STANDARD_DEVIATION 6.7
Cynicism/distrust of others' intentions5.3 units on a scale
STANDARD_DEVIATION 1.7
5.7 units on a scale
STANDARD_DEVIATION 1.6
4.8 units on a scale
STANDARD_DEVIATION 1.7
Depression1.7 units on a scale
STANDARD_DEVIATION 2.7
2.1 units on a scale
STANDARD_DEVIATION 3.4
1.2 units on a scale
STANDARD_DEVIATION 1.8
Education level
College graduate or higher
91 Participants40 Participants51 Participants
Education level
HS graduate or HS equivalent (GED)
108 Participants64 Participants44 Participants
Education level
Less than high school (HS) graduate
44 Participants30 Participants14 Participants
Education level
Some college or tech school
206 Participants90 Participants116 Participants
Employment Status
Employed full-time
219 Participants77 Participants142 Participants
Employment Status
Employed part-time
70 Participants41 Participants29 Participants
Employment Status
Not currently employed
103 Participants75 Participants28 Participants
Employment Status
Retired
16 Participants11 Participants5 Participants
Employment Status
Student/homemaker
41 Participants20 Participants21 Participants
Financial strain15.1 units on a scale
STANDARD_DEVIATION 4.2
15.6 units on a scale
STANDARD_DEVIATION 4.3
14.6 units on a scale
STANDARD_DEVIATION 4.1
Health insurance that pays for most medical care
No
209 Participants107 Participants102 Participants
Health insurance that pays for most medical care
Yes
240 Participants117 Participants123 Participants
Height in inches66.8 inches
STANDARD_DEVIATION 3.8
66.8 inches
STANDARD_DEVIATION 3.7
66.8 inches
STANDARD_DEVIATION 3.9
Housing
Own a home
115 Participants38 Participants77 Participants
Housing
Rent or stay with others
334 Participants186 Participants148 Participants
Income28,566 Dollars21,293 Dollars35,806 Dollars
Longest quit attempt in months25.0 months
STANDARD_DEVIATION 62
24.8 months
STANDARD_DEVIATION 70.9
25.3 months
STANDARD_DEVIATION 51.7
Menthol smoker
Menthol
252 Participants193 Participants59 Participants
Menthol smoker
Non-menthol
197 Participants31 Participants166 Participants
Neighborhood problems14.5 units on a scale
STANDARD_DEVIATION 4.2
15.5 units on a scale
STANDARD_DEVIATION 4.7
13.5 units on a scale
STANDARD_DEVIATION 3.4
Neuroticism/proneness to psychological stress12.5 units on a scale
STANDARD_DEVIATION 6.7
12.6 units on a scale
STANDARD_DEVIATION 7.1
12.5 units on a scale
STANDARD_DEVIATION 6.3
Number of people living in house, including self2.8 Cohabitants
STANDARD_DEVIATION 1.7
2.7 Cohabitants
STANDARD_DEVIATION 1.6
3.0 Cohabitants
STANDARD_DEVIATION 1.8
Number of smokers in the home(not including self)0.6 cohabitants
STANDARD_DEVIATION 0.9
0.6 cohabitants
STANDARD_DEVIATION 1
0.6 cohabitants
STANDARD_DEVIATION 0.8
Number of your five best friends smoke2.8 friends
STANDARD_DEVIATION 1.8
2.9 friends
STANDARD_DEVIATION 1.8
2.7 friends
STANDARD_DEVIATION 1.7
Partner smoking status
No partner/spouse
172 Participants94 Participants78 Participants
Partner smoking status
Partner/spouse is a non-smoker
137 Participants68 Participants69 Participants
Partner smoking status
Partner/spouse is a smoker
140 Participants62 Participants78 Participants
Perceived discrimination
frequency encountered
5.9 units on a scale
STANDARD_DEVIATION 4.9
6.8 units on a scale
STANDARD_DEVIATION 5.1
5.1 units on a scale
STANDARD_DEVIATION 4.1
Perceived discrimination
number of situations encountered
2.7 units on a scale
STANDARD_DEVIATION 1.6
2.7 units on a scale
STANDARD_DEVIATION 1.6
2.6 units on a scale
STANDARD_DEVIATION 1.6
Perceived Health
Good, fair, or poor
238 Participants125 Participants113 Participants
Perceived Health
Very good/excellent
211 Participants99 Participants112 Participants
Perceived social status4.9 units on a scale
STANDARD_DEVIATION 1.5
4.8 units on a scale
STANDARD_DEVIATION 1.5
5.0 units on a scale
STANDARD_DEVIATION 1.5
Perceived stress4.1 units on a scale
STANDARD_DEVIATION 2.6
4.5 units on a scale
STANDARD_DEVIATION 2.7
3.6 units on a scale
STANDARD_DEVIATION 2.3
Percent Federal Poverty Level
101%-200%
159 Participants72 Participants87 Participants
Percent Federal Poverty Level
201%-250%
40 Participants15 Participants25 Participants
Percent Federal Poverty Level
251%-300%
36 Participants9 Participants27 Participants
Percent Federal Poverty Level
301%-400%
56 Participants13 Participants43 Participants
Percent Federal Poverty Level
< or = 100%
158 Participants115 Participants43 Participants
Race Consciousness
At least daily
61 Participants54 Participants7 Participants
Race Consciousness
Never
267 Participants109 Participants158 Participants
Race Consciousness
Once a month
40 Participants22 Participants18 Participants
Race Consciousness
Once a week
31 Participants14 Participants17 Participants
Race Consciousness
Once a year
50 Participants25 Participants25 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
224 Participants224 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
225 Participants0 Participants225 Participants
Satisfaction with life22.0 units on a scale
STANDARD_DEVIATION 6.2
20.1 units on a scale
STANDARD_DEVIATION 6.3
23.8 units on a scale
STANDARD_DEVIATION 5.5
Sex: Female, Male
Female
224 Participants112 Participants112 Participants
Sex: Female, Male
Male
225 Participants112 Participants113 Participants
Social cohesion and trust17.0 units on a scale
STANDARD_DEVIATION 4.7
16.2 units on a scale
STANDARD_DEVIATION 4.7
17.8 units on a scale
STANDARD_DEVIATION 4.5
Time to first cigarette
After 30 minutes
104 Participants47 Participants57 Participants
Time to first cigarette
Within 30 minutes
345 Participants177 Participants168 Participants
Waist circumference in inches37.0 inches
STANDARD_DEVIATION 6.4
37.6 inches
STANDARD_DEVIATION 6.7
36.3 inches
STANDARD_DEVIATION 6.2
Weight in pounds189.1 pounds
STANDARD_DEVIATION 48.1
195.3 pounds
STANDARD_DEVIATION 51.2
182.9 pounds
STANDARD_DEVIATION 44.1
Withdrawal5.3 units on a scale
STANDARD_DEVIATION 3.8
5.3 units on a scale
STANDARD_DEVIATION 4.3
5.2 units on a scale
STANDARD_DEVIATION 3.1

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 2241 / 225
other
Total, other adverse events
210 / 224206 / 225
serious
Total, serious adverse events
1 / 2245 / 225

Outcome results

Primary

Number of Participants With Cotinine-verified 7-day Point Prevalence Smoking Abstinence at Week 26

Defined as having no cigarettes for the previous 7 days at the Week 26 visit. The recommended cut-off of 15ng/ml for salivary cotinine will be used to differentiate smokers from non-smokers.

Time frame: Change from Baseline to Week 26

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
African American (AA) SmokersNumber of Participants With Cotinine-verified 7-day Point Prevalence Smoking Abstinence at Week 2632 Participants
White SmokersNumber of Participants With Cotinine-verified 7-day Point Prevalence Smoking Abstinence at Week 2655 Participants

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026